Zepp Health Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Los beneficios de Zepp Health han disminuido a una tasa media anual de -53.8%, mientras que en la industria Electronic los beneficios crecieron en un 3.8% anualmente. Los ingresos han ido disminuyendo a una tasa media de 36.8% al año.
Información clave
-53.75%
Tasa de crecimiento de los beneficios
-53.16%
Tasa de crecimiento del BPA
| Crecimiento de la industria Electronic | 15.34% |
| Tasa de crecimiento de los ingresos | -36.84% |
| Rentabilidad financiera | -18.68% |
| Margen neto | -15.48% |
| Última actualización de beneficios | 31 Dec 2025 |
Actualizaciones de resultados anteriores recientes
Recent updates
Zepp Health: A Riskier Bet As Gross Margins Compress (Rating Downgrade)
Summary Zepp Health has shifted from a buy to a neutral rating due to persistent unprofitability and margin concerns. Despite >40% y/y revenue growth in Amazfit, ZEPP faces tough comps and macro headwinds that threaten sustained double-digit expansion. Gross margins remain in the high 30s, ~20 points below Garmin, limiting ZEPP’s scalability and profit potential. With abundant high-quality software bargains available, I see little justification to maintain or add to ZEPP positions. Read the full article on Seeking AlphaInvestors Aren't Entirely Convinced By Zepp Health Corporation's (NYSE:ZEPP) Revenues
With a price-to-sales (or "P/S") ratio of 2x Zepp Health Corporation ( NYSE:ZEPP ) may be sending bullish signals at...Market Participants Recognise Zepp Health Corporation's (NYSE:ZEPP) Revenues Pushing Shares 28% Higher
Despite an already strong run, Zepp Health Corporation ( NYSE:ZEPP ) shares have been powering on, with a gain of 28...Just In: One Analyst Has Become A Lot More Bullish On Zepp Health Corporation's (NYSE:ZEPP) Earnings
Zepp Health Corporation ( NYSE:ZEPP ) shareholders will have a reason to smile today, with the covering analyst making...
GDPR Pressures And AI Health Developments Will Shape Future Markets
Zepp Health's consensus price target has surged, primarily reflecting sharply higher expected revenue growth and a much richer projected valuation multiple, now placing fair value at $60.23. What's in the News Zepp Health issued Q3 2025 revenue guidance of $72–76 million, projecting a 23–35% year-over-year increase from $42.5 million.Zepp Health Corporation (NYSE:ZEPP) Soars 336% But It's A Story Of Risk Vs Reward
Zepp Health Corporation ( NYSE:ZEPP ) shareholders have had their patience rewarded with a 336% share price jump in the...Investors Give Zepp Health Corporation (NYSE:ZEPP) Shares A 29% Hiding
Zepp Health Corporation ( NYSE:ZEPP ) shares have had a horrible month, losing 29% after a relatively good period...
AI-powered T-Rex 3 And Amazfit Releases Will Redefine Future Possibilities
Transition to a high-margin business model and AI-powered product launches likely to enhance profitability and drive significant revenue growth.Zepp Health Corporation (NYSE:ZEPP) Stock Catapults 26% Though Its Price And Business Still Lag The Industry
Zepp Health Corporation ( NYSE:ZEPP ) shareholders are no doubt pleased to see that the share price has bounced 26% in...Calculating The Intrinsic Value Of Zepp Health Corporation (NYSE:ZEPP)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Zepp Health fair value estimate is US$0.56 Zepp Health's...Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
To the annoyance of some shareholders, Zepp Health Corporation ( NYSE:ZEPP ) shares are down a considerable 27% in the...Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30%
The Zepp Health Corporation ( NYSE:ZEPP ) share price has done very well over the last month, posting an excellent gain...Zepp Leaves Investors Guessing With Return To Profits, Tumbling Own-Brand Sales
Summary Zepp returned to profitability in the third quarter for the first time since 2021, as its margins jumped with the development of its own Amazfit brand. The company’s shares initially rose sharply after the report, but then fell even more, as investors worried about a big drop in sales of its own-brand products. Zepp’s latest valuation metrics look ridiculously low, including a forward P/E ratio of just 3.1 and a P/S ratio of 0.14. Read the full article on Seeking AlphaCan Zepp Health Find Its Way Back Up?
Summary Zepp Health has had the most tumultuous two years. The share price plummeted 88%, and revenue is down by almost 50%. At this point, is ZEPP stock worth investing in? Read the full article on Seeking AlphaZepp Health Non-GAAP EPADS of -$0.23, revenue of $165.5M
Zepp Health press release (NYSE:ZEPP): Q2 Non-GAAP EPADS of -$0.23. Revenue of $165.5M (-39.6% Y/Y). Total units shipped in the second quarter 2022 decreased by 45.2% year-over-year to 6.3M, compared with 11.5M in the second quarter of 2021. For the third quarter of 2022, the management of the company currently expects: Net revenues to be between RMB1.2 billion and RMB1.5 billion, compared with RMB1.61 billion in the third quarter of 2021 vs. estimated growth of 23.50% Y/Y.What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?
Zepp Health Corporation ( NYSE:ZEPP ), might not be a large cap stock, but it saw a decent share price growth in the...Desglose de ingresos y gastos
Cómo gana y gasta dinero Zepp Health. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 25 | 259 | -40 | 83 | 45 |
| 30 Sep 25 | 233 | -66 | 76 | 45 |
| 30 Jun 25 | 200 | -78 | 76 | 45 |
| 31 Mar 25 | 181 | -81 | 74 | 45 |
| 31 Dec 24 | 183 | -76 | 71 | 46 |
| 30 Sep 24 | 209 | -39 | 69 | 46 |
| 30 Jun 24 | 237 | -25 | 64 | 44 |
| 31 Mar 24 | 296 | -25 | 68 | 47 |
| 31 Dec 23 | 353 | -31 | 71 | 52 |
| 30 Sep 23 | 417 | -40 | 79 | 56 |
| 30 Jun 23 | 492 | -41 | 85 | 62 |
| 31 Mar 23 | 587 | -49 | 98 | 71 |
| 31 Dec 22 | 614 | -43 | 103 | 77 |
| 30 Sep 22 | 665 | -25 | 103 | 70 |
| 30 Jun 22 | 766 | -16 | 106 | 71 |
| 31 Mar 22 | 924 | 14 | 111 | 80 |
| 31 Dec 21 | 983 | 22 | 110 | 81 |
| 30 Sep 21 | 1,017 | 34 | 103 | 85 |
| 30 Jun 21 | 1,114 | 38 | 111 | 95 |
| 31 Mar 21 | 991 | 26 | 102 | 87 |
| 31 Dec 20 | 986 | 35 | 95 | 82 |
| 30 Sep 20 | 968 | 47 | 86 | 81 |
| 30 Jun 20 | 877 | 63 | 71 | 71 |
| 31 Mar 20 | 861 | 73 | 66 | 67 |
| 31 Dec 19 | 835 | 82 | 62 | 62 |
| 30 Sep 19 | 689 | 67 | 53 | 53 |
| 30 Jun 19 | 603 | 57 | 51 | 45 |
| 31 Mar 19 | 575 | 58 | 47 | 39 |
| 31 Dec 18 | 530 | 16 | 45 | 38 |
| 30 Sep 18 | 462 | 4 | 39 | 33 |
| 30 Jun 18 | 389 | -10 | 30 | 30 |
| 31 Mar 18 | 367 | -22 | 29 | 30 |
| 31 Dec 17 | 315 | 7 | 24 | 24 |
| 30 Sep 17 | 287 | 8 | 24 | 21 |
| 31 Dec 16 | 224 | -2 | 19 | 19 |
| 31 Dec 15 | 138 | -9 | 14 | 9 |
Ingresos de calidad: ZEPP actualmente no es rentable.
Margen de beneficios creciente: ZEPP actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: ZEPP no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 53.8% al año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de ZEPP en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: ZEPP no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Electronic (13.4%).
Rentabilidad financiera
Alta ROE: ZEPP tiene una rentabilidad financiera negativa (-18.68%), ya que actualmente no es rentable.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/21 23:11 |
| Precio de las acciones al final del día | 2026/05/21 00:00 |
| Beneficios | 2025/12/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Zepp Health Corporation está cubierta por 3 analistas. 1 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Ang-Chi Lin | Citigroup Inc |
| Siddharth Rajeev | Fundamental Research Corp. |
| Jones Ku | Haitong International Research Limited |